Investigating the Influence of Vaccine Literacy, Vaccine Perception and Vaccine Hesitancy on Israeli Parents’ Acceptance of the COVID-19 Vaccine for Their Children: A Cross-Sectional StudyArticle Published on 2021-11-242022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] 95%CI acceptance approved children children’s vaccination combating component correlated COVID-19 COVID-19 vaccination COVID-19 vaccine effective facilitator FDA health-care Hesitancy indicated influence information Intention Internet introduced literacy parent Perception positive Providing Psychological questionnaire receive recruited significantly socio-demographic the vaccine understanding vaccinate vaccination Vaccine Vaccine acceptance Vaccine hesitancy vaccine literacy vaccine perception was measured with COVID-19 [DOI] 10.3390/vaccines9121391 PMC 바로가기 [Article Type] Article
A Local Survey of COVID-19: Vaccine Potential Acceptance Rate among Personnel in a Level 1 Trauma Center without Severe COVID-19 CasesArticle Published on 2021-11-232022-10-31 Journal: International journal for equity in health [Category] COVID-19, [키워드] acceptance Administered age amplified category center China chose conducted COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine difference effective Factors female genders group HCW HCWs health care workers healthcare healthcare worker high risk hospital immune system IMPROVE individual infection control infection risk Intention knowledge less level 1 level 1 trauma majority male Nurse Older age pandemic participant Patient Potential Prevent PROTECT public health questionnaire Randomly ranged Rate receive reported Result risk Russia spread of COVID-19 survey the vaccine trauma vaccination Vaccine Vaccine hesitancy Variation [DOI] 10.3390/healthcare9121616 PMC 바로가기 [Article Type] Article
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyMulticenter Study Published on 2021-11-232022-10-04 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), MERS, SARS, 변종, 치료법, [키워드] 95% CI acute respiratory syndrome adjusted odds ratio Alter Anti-spike antibody B.1.617.2 Breakthrough infection breakthrough infections Clinical features cohort study conducted coronavirus COVID-19 COVID-19 pandemic Delta delta variant Diagnosis effective effective vaccine faster group hospital in viral individual individuals Infection mRNA vaccine multicentre objective Older age oxygen supplementation Patient PCR cycle Protein Result retrospective cohort study RNA robust SARS-CoV-2 SARS-COV-2 infection serological serological response severe COVID-19 significantly significantly lower Singapore Spread symptomatic the vaccine threshold value titre titres vaccinated individuals vaccination Vaccine Vaccine breakthrough vaccine strain variants of concern Viral load Virological Virus neutralization wildtype [DOI] 10.1016/j.cmi.2021.11.010 PMC 바로가기 [Article Type] Multicenter Study
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple MyelomaConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 유전자 메커니즘, [키워드] addition Affect antibody Antibody Response Antibody titer Antigen AstraZeneca authors average Bayer Bluebird BMS board Cancer CAR Cell cellular immunity Characteristics conducted COVID COVID-19 COVID-19 antibody COVID-19 infection COVID-19 vaccination COVID-19 vaccine CRBN current Daichii Sankyo Debiopharm Deceased died download education eligible evaluated False positive figure for inclusion Frequency funding Genmab Glaxo healthy donors hematologic Hematologic malignancy humoral IgG antibody Immunocompromised Immunoglobulin immunologic response immunosuppressive individual Infection janssen life majority malignancies Mayo Clinic median medical records Mortality multicenter Multiple Multiple myeloma Myeloma national guideline NHL Non-Hodgkin Lymphoma offered Patent Patient Pfizer populations positive receive receptor recipient recipients Regeneron reported response Retrospective study SARS-CoV-2 Seattle Seroconversion seroconversion rate small sample size speaker submission survived T-cell tested the timing the vaccine Therapeutics therapy Treatment Trillium vaccination [DOI] 10.1182/blood-2021-151859 [Article Type] Conference abstract
Inflammation and Platelet Activation After COVID-19 Vaccines – Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and ThrombosisCOVID-19 백신 후 염증 및 혈소판 활성화 - 백신 유도 면역 혈소판 감소증 및 혈전증 뒤에 가능한 메커니즘Controlled Clinical Trial Published on 2021-11-232022-09-12 Journal: Frontiers in Immunology [Category] MERS, SARS, 임상, 진단, [키워드] Activation Adenovirus age aggregation antibodies antibody antibody production cascade Coagulation complex Complication component COVID-19 COVID-19 pandemic COVID-19 vaccine CRP E-selectin endothelial Epidemiological study event excessive inflammation Gender groups Head-to-head comparison healthy controls ICAM-1 IL-10 IL-1β IL-6 IL-8 increase in individual Inflammation Inflammatory initial Johnson & Johnson marker mRNA mRNA vaccination mRNA vaccine P-selectin pathogenesis of COVID-19 PF4 Platelet platelet activation platelet factor 4 positive promote proportion Prospective Study provided TGF-β the vaccine threshold thrombin thrombocytopenia Thromboembolic event thrombosis TNF-α TTS vaccinated individual vaccination Vaccine Vaccines Vascular VCAM-1 VITT Whole blood [DOI] 10.3389/fimmu.2021.779453 PMC 바로가기 [Article Type] Controlled Clinical Trial
Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy PopulationArticle Published on 2021-11-232022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] Administered adverse event Antibody Response BNT162b2 mRNA boost booster Cellular immune response comparable conducted CoronaVac country Coverage COVID-19 COVID-19 pandemic Delta dosage dose effective Effects examined healthy IgG immunogenicity inactivated inactivated SARS-CoV-2 Intradermal intramuscular Intramuscular injection introduced less local reaction management mRNA vaccine neutralising observé of BNT162b2 participant Phase I Population provide provided randomised receiving recruited reduce regimen remained Safety SARS-CoV-2 serum significantly systemic reaction systemic side effects T cell response the vaccine Trial vaccination Vaccine vaccine immunogenicity Volunteer [DOI] 10.3390/vaccines9121375 PMC 바로가기 [Article Type] Article
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysisCovid-19 백신의 임상 효능 비교 : 체계적인 검토 및 네트워크 메타 분석Meta-Analysis Published on 2021-11-232022-08-31 Journal: Scientific Reports [Category] MERS, meta-analysis, SARS, 임상, [키워드] Above acute respiratory syndrome Ad26.COV2.S assessment assessment tool Bia BNT162b2 Clinical efficacy clinical trial comparison controlled trials CoronaVac coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine database Efficacy eight Epidemiology evaluated Factor followed by Gam-COVID-Vac greater highest Intervention leading logistics mRNA mRNA-1273 mRNA-1273 vaccine mRNA-1273 vaccines Network meta-analysis New nine NMA no statistically significant difference pandemic participant Patient performed Phase 3 Prevent Primary outcome Primary outcomes Probability Randomized controlled trial RCT RCTs registration number respiratory risk risk of bia SARS-CoV-2 searched severe COVID-19 severe disease Side effects significantly statistically statistically significant difference symptomatic symptomatic COVID-19 symptomatic disease systematic review the vaccine the vaccines unique Vaccine Vaccines viral infection was tested while [DOI] 10.1038/s41598-021-02321-z PMC 바로가기 [Article Type] Meta-Analysis
High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19Article Published on 2021-11-222022-10-04 Journal: Communications Biology [Category] MERS, SARS, 바이오마커, 변종, 진단, [키워드] Adaptive immunity analyzed antibody epitopes Antibody Response Antigen applied approach Bacterial binding coronavirus 2 Coronaviruses COVID-19 cross-reactive D614G Data mining data-driven Diagnostic markers disease severity dominant epitope effective vaccine elicit epitope epitope mapping Evolution of SARS-CoV-2 highlight humoral identify immune response in silico analysis infected patient large cohort Mild motif mutant Mutant SARS-CoV-2 neutralization activity organism other coronavirus Patient peptide platform proteome proteomes random reduced Region repertoire respiratory SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 epitope SARSCoV-2 serum samples severe disease specificity Spread Strains subject the vaccine Therapies therapy treat viral infection with COVID-19 [DOI] 10.1038/s42003-021-02835-2 PMC 바로가기 [Article Type] Article
COVID-19 vaccine preferences among university students in Hong Kong: a discrete choice experimentResearch Note Published on 2021-11-222022-10-27 Journal: BMC Research Notes [Category] COVID-19, [키워드] activities Adverse reactions age applied conducted COVID-19 vaccination COVID-19 vaccine determinant discrete choice experiment dose driver Efficacy experiment Factor Health Health Education Hong Kong imperative IMPROVE Influenza logit objective overcome preference Preference and vaccination decision promote public health questionnaire Regression required Result Safety Sex subject supplementary material the vaccine vaccination Vaccine Vaccine hesitancy Weighting [DOI] 10.1186/s13104-021-05841-z PMC 바로가기 [Article Type] Research Note
COVID-19 vaccine preferences among university students in Hong Kong: a discrete choice experimentResearch Note Published on 2021-11-222022-10-27 Journal: BMC Research Notes [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] activities Adverse reactions age applied conducted COVID-19 vaccination COVID-19 vaccine determinant discrete choice experiment dose driver Efficacy experiment Factor Health Health Education Hong Kong imperative IMPROVE Influenza logit objective overcome preference Preference and vaccination decision promote public health questionnaire Regression required Result Safety Sex subject supplementary material the vaccine vaccination Vaccine Vaccine hesitancy Weighting [DOI] 10.1186/s13104-021-05841-z PMC 바로가기 [Article Type] Research Note